2022, Nakao M, Nakamura Y, Shimokawa M, Maeda H. Postmarketing all-case surveillance trends and contribution to safety measures of drugs approved in Japan: a cross-sectional survey in 1999-2019. Int J Clin Pharm. 2022 Nov 2. doi: 10.1007/s11096-022-01461-0